Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical study is to compare the lung exposure of the contents of the trial
drug after administration of the fixed combination between beclomethasone and formoterol
delivered via the new Chiesi dry powder inhaler in comparison to the beclomethasone and
formoterol delivered via the pressurised metered dose inhaler (pMDI) using a spacer device.
To determine lung exposure, the treatments are administered with charcoal block.